Expert consensus on management of metabolic disease in Chinese liver transplant recipients

Table 4 Monitoring of metabolic disease after liver transplantation

Metabolic disease	Monitoring indicator	Target	Other related examination items
Diabetes mellitus	FPG, HbA1c, and OGTT	FPG < 6.7 mmol/L, peak value < 8.88 mmol/L or HbA1c < 7%	Urinary protein, ophthalmoscopy, B-mode ultrasonography of the carotid artery, and coronary CT angiography
Hypertension	Arterial pressure	Arterial pressure < 130/80 mmHg	24-h ambulatory blood pressure, ECG, coronary CT angiography, urinary protein, ophthalmoscopy
Dyslipidemia	LDL-C, TC, TG	LDL-C < 100 mg/dL; patients with cardiovascular risk factors, LDL-C < 70 mg/dL	ECG, B-mode ultrasonography of the carotid artery and coronary CT angiography
Hyperuricemia	SUA	SUA < 360 μmol/L; patients with gout attack, SUA < 300 μmol/L	Urinary protein, serum creatinine, glomerular filtration rate, bilateral renal ultrasound, joint ultrasound, joint X-ray or CT
Obesity	BMI	BMI < 25 kg/m2	Coronary CT angiography and B-mode ultrasonography of the carotid artery

CT: Computed tomography; ECG: Electrocardiogram; SUA: Serum uric acid; BMI: Body mass index; LDL-C: Low density lipoprotein cholesterol; TC: Cholesterol; TG: Triglycerides; FPG: Fasting plasma glucose; HbA1c: Glycated hemoglobin; OGTT: Oral glucose tolerance test.